HACE1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.805500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.697600E-01
Normal-vs-Stage2
4.996200E-02
Normal-vs-Stage3
1.677550E-02
Normal-vs-Stage4
1.234390E-01
Stage1-vs-Stage2
6.571200E-01
Stage1-vs-Stage3
5.359400E-01
Stage1-vs-Stage4
8.114200E-01
Stage2-vs-Stage3
6.130000E-01
Stage2-vs-Stage4
4.780600E-01
Stage3-vs-Stage4
1.387570E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.604500E-02
Normal-vs-AfricanAmerican
2.095800E-01
Normal-vs-Asian
1.044370E-01
Caucasian-vs-AfricanAmerican
5.987800E-01
Caucasian-vs-Asian
3.699200E-01
AfricanAmerican-vs-Asian
4.135600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.717900E-02
Normal-vs-Female
1.227440E-01
Male-vs-Female
1.756840E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.703600E-02
Normal-vs-Age(41-60Yrs)
2.091400E-01
Normal-vs-Age(61-80Yrs)
5.308500E-02
Normal-vs-Age(81-100Yrs)
3.358300E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.933600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.727800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.650400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.620100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.194190E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.784600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.390300E-02
Normal-vs-Daily Drinker
2.028400E-02
Normal-vs-Weekly Drinker
2.706500E-02
Normal-vs-Occasional Drinker
3.359000E-01
Normal-vs-Social Drinker
3.400400E-01
Non Drinker-vs-Daily Drinker
7.383600E-01
Non Drinker-vs-Weekly Drinker
8.483800E-01
Non Drinker-vs-Occasional Drinker
1.304590E-01
Non Drinker-vs-Social Drinker
1.402010E-01
Daily Drinker-vs-Weekly Drinker
6.259000E-01
Daily Drinker-vs-Occasional Drinker
9.504400E-02
Daily Drinker-vs-Social Drinker
1.010450E-01
Weekly Drinker-vs-Occasional Drinker
2.629400E-01
Weekly Drinker-vs-Social Drinker
2.624000E-01
Occasional Drinker-vs-Social Drinker
9.867800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.480360E-01
Normal-vs-Grade 2
5.470400E-02
Normal-vs-Grade 3
1.406850E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.202800E-01
Grade 1-vs-Grade 3
3.434400E-01
Grade 1-vs-Grade 4
1.480360E-01
Grade 2-vs-Grade 3
9.790600E-01
Grade 2-vs-Grade 4
5.470400E-02
Grade 3-vs-Grade 4
1.406850E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.397700E-02
Normal-vs-NonDiabetic
6.248100E-02
Diabetic-vs-NonDiabetic
7.605800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.170170E-02
Normal-vs-NoPancreatitis
8.054100E-02
Pancreatitis-vs-NoPancreatitis
2.585600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.167640E-01
Normal-vs-N1
5.062100E-02
N0-vs-N1
4.813400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.700080E-02
Normal-vs-TP53-NonMutant
2.440000E-01
TP53-Mutant-vs-TP53-NonMutant
8.803200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
